Expand RGNX Menu
RGNX MENU

RGNX Latest Press Releases

-- December 18, 2025 --

REGENXBIO to Present at the 44th Annual J.P. Morgan Healthcare Conference PRNewswire 7:05 AM

-- November 25, 2025 --

REGENXBIO to Participate in Upcoming Investor Conference PRNewswire 7:05 AM

-- November 6, 2025 --

REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights PRNewswire 7:05 AM

-- October 30, 2025 --

REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy Program PRNewswire 7:05 AM

-- October 29, 2025 --

REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational Highlights PRNewswire 7:05 AM

-- October 15, 2025 --

REGENXBIO to Participate in Upcoming Investor Conferences PRNewswire 7:05 AM

-- October 9, 2025 --

REGENXBIO Announces Presentation at the American Academy of Ophthalmology 2025 Annual Meeting PRNewswire 7:05 AM

-- October 6, 2025 --

REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD PRNewswire 7:05 AM

-- September 29, 2025 --

REGENXBIO Announces Presentation at the World Muscle Society PRNewswire 7:05 AM

-- September 5, 2025 --

REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITE Trial of RGX-121 for Treatment of MPS II PRNewswire 7:05 AM

-- August 28, 2025 --

REGENXBIO to Participate in Upcoming Investor Conferences PRNewswire 7:06 AM

-- August 18, 2025 --

REGENXBIO Announces FDA Review Extension of BLA for RGX-121 to Treat Patients with MPS II PRNewswire 5:00 PM

-- August 7, 2025 --

REGENXBIO Reports Second Quarter 2025 Financial Results and Operational Highlights PRNewswire 7:05 AM
REGENXBIO Announces Pivotal Program for Surabgene Lomparvovec in Diabetic Retinopathy PRNewswire 7:00 AM

-- July 31, 2025 --

REGENXBIO to Host Conference Call on August 7 to Discuss Second Quarter 2025 Financial Results and Operational Highlights PRNewswire 7:05 AM
Market Data Delayed 15 Minutes